Open research questions in Ocular Diseases and Behçet’s Syndrome
92 gap statements mined from Ocular Diseases and Behçet’s Syndrome papers in our 4.5M-paper local library, which holds 526 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.
Choosing where to publish on Ocular Diseases and Behçet’s Syndrome? See the ranked Medicine journals.
What the literature leaves open
First, therapies is still limited by small sample sizes, retrospective study design, and marked disease heterogeneity, underscoring the need for adequately powered randomized controlled trials to validate early efficacy signals and define optimal positioning within treatment algorithms.
There is a lack of broadly applicable treatments for retinitis pigmentosa. Most patients still lack access to effective treatments. There is a need for further research into anti-inflammatory strategies for inherited retinal degeneration.
Intravitreal Adalimumab in Retinitis Pigmentosa: A Prospective Pilot Study Assessing Ocular Safety and Feasibility · 2026 · DOIThe results do not establish a clinically specific or causal relationship, and further studies incorporating clinically validated uveitis phenotypes are warranted to clarify this association. Also, causality cannot be inferred from this study, and further prospective and mechanistic investigations are warranted to clarify the underlying relationship.
Human papillomavirus infection and the risk of uveitis: a propensity-score-matched electronic health record study · 2026 · DOIAs Colucciello noted, the etiology of ARPE remains incompletely understood; however, it is widely hypothesized to have an inflammatory origin, potentially provoked by viral infections or immune system dysregulation.
ARPE – acute retinal pigment epitheliitis as a rare inflammatory disorder of the retina · 2026 · DOIThe reviewed studies show substantial variation in the prevalence of ocular symptoms. Limitations of many analyses included small sample sizes, lack of control groups, and retrospective study design. The discrepancy in the prevalence of ocular symptoms likely results from methodological differences.
The review highlights the need for further prospective studies to elucidate underlying mechanisms, prevalence, and long-term consequences. The study emphasizes the importance of considering ocular symptoms in the diagnosis and management of COVID-19. The review highlights the need for ophthalmologic vigilance in patients with COVID-19.
The study had a limited sample size. The achieved power (1-β) was 0.98 for PIV and 0.77 for SII at a significance level of 0.05.
Diagnostic and Potentially Prognostic Value of Novel Inflammatory Indices in Non-Arteritic Anterior Ischemic Optic Neuropathy · 2026 · DOIThe pathogenesis of NAION remains incompletely understood. The predictive value of inflammatory markers in NAION is not well established.
Diagnostic and Potentially Prognostic Value of Novel Inflammatory Indices in Non-Arteritic Anterior Ischemic Optic Neuropathy · 2026 · DOIMultiple evanescent white dot syndrome (MEWDS) is likewise included, although its pathophysiology remains debated, particularly regarding whether the primary target is the choriocapillaris or the photoreceptors.
From white dot syndromes to primary inflammatory choriocapillaropathies (PICCPs): updating and expanding the spectrum through multimodal imaging · 2026 · DOIThe lack of longitudinal data. The limited understanding of the psychological burden of Behçet disease.
Psychological Burden in Behçet Disease: A Narrative Review Across Mucocutaneous, Articular, and Ocular Manifestations · 2026 · DOIFuture research should prioritize prospective and multicenter studies. Studies should use clearer diagnostic and phenotypic characterization, standardized psychiatric and quality-of-life measures. Research should investigate the impact of mucocutaneous, articular, and ocular manifestations on patients' psychological well-being.
Psychological Burden in Behçet Disease: A Narrative Review Across Mucocutaneous, Articular, and Ocular Manifestations · 2026 · DOIWhile this supports the detection of CVA24v during the outbreak, it is insufficient to establish definitive causation, precludes analysis of viral diversity or within-outbreak transmission dynamics, and prevents conclusions regarding the role of CVA24v in outbreaks in other regions or at earlier time points.
Detection of Coxsackievirus A24v during an acute haemorrhagic conjunctivitis outbreak in Dar es Salaam, Tanzania, January-February 2024 · 2026 · DOIThe present study augments this limited literature by reporting on a larger patient cohort with an extended follow-up period. However, published data on SPC remain scarce, and existing reports are limited by relatively short follow-up durations.
Clinical characteristics and prognosis of solitary punctate chorioretinitis in Chinese patients · 2026 · DOIThere is a lack of comprehensive epidemiological characterization of uveitis in the elderly population. Prior studies have highlighted differing common diagnoses for uveitis in elderly patients.
Epidemiological characterization of uveitis in the elderly population: a systematic review and meta-analysis · 2026 · DOILimited understanding of the molecular mechanisms underlying ATRA's effects on macrophage activity and systemic inflammation. Lack of effective therapies for managing cytokine storms.
All-trans retinoic acid suppresses systemic inflammation induced by severe fever with thrombocytopenia syndrome virus in mice · 2026 · DOILimited evidence regarding the safety and efficacy of surgical management for NLDO in immunocompromised patients. Underrecognition of NLDO as a manifestation of ocular GVHD.
Nasolacrimal duct obstruction following allo-HSCT: an overlooked manifestation of ocular graft-versus-host disease · 2026 · DOIAs a chronic inflammatory disease, its exact cause remains unclear, but genetic predisposition, immune dysfunction, and environmental factors are key contributors17–19.
Upregulation of serum circular RNA FUNDC1 and TNF-α in Behçet’s disease: potential diagnostic biomarkers · 2026 · DOIIdiopathic pediatric uveitis (IPU) is a leading cause of irreversible vision loss in children; however, the genetic and molecular mechanisms underlying this condition remain unclear.
A Rare De Novo Missense Mutation in IFT122 Confers a Genetic Susceptibility Factor of Idiopathic Pediatric Uveitis Via Trio‐based Whole‐Exome Sequencing · 2026 · DOIAlthough effective antiviral immunity is essential for controlling HSV-1 and limiting recurrent disease, the mechanisms regulating recruitment of protective lymphocytes to the ocular mucosa remain incompletely understood.
Tissue-Resident and Effector-Memory Lymphocyte Recruitment to the Ocular Mucosa Requires CCL28/CCR10 Signaling During Recurrent HSV-1 Infection · 2026 · DOIFuture larger multicenter studies using multi-omics approaches are warranted to further elucidate the complex pathogenesis of PSS and develop more effective therapeutic strategies.
Integrated pathogen detection and immune profiling in posner-schlossman syndrome: a metagenomic and cytokine approach · 2026 · DOIThere is a notable gap in understanding the health-related quality of life (HRQoL) impact on carers of people with XLRP, essential for holistic health economic evaluations.
X-Linked Retinitis Pigmentosa (XLRP): An Investigation of the Impact of XLRP on Health-Related Quality of Life of Carers in Great Britain · 2026 · DOIIn addition, HLA typing, including HLA-B27 testing, was not routinely performed; therefore, the association between HLA-B27 and AAU could not be evaluated in this study.
Pattern of uveitis in first-time patients at a tertiary referral center in Saitama, Japan · 2026 · DOIThe temporal relationship between uveitis and neurological relapses in multiple sclerosis (MS)–associated uveitis is poorly documented; and MS-targeted disease-modifying therapies (DMTs) may influence the ocular course.
Clinical course of multiple sclerosis-associated uveitis: a retrospective series of 49 cases · 2026 · DOIThe difficulty in achieving definitive diagnosis of ocular tuberculosis due to the low sensitivity of culture and PCR from aqueous or vitreous humor. The importance of considering presumed ocular tuberculosis in the differential diagnosis of uveitis of uncertain etiology.
Presumed Bilateral Ocular Tuberculosis in a Young Patient - Diagnostic Approach and Follow-Up: Case Report · 2026 · DOIBy integrating these pathways and molecular markers, we propose an updated mechanistic framework, including a conceptual model for the underexplored role of heparanase, and identify pathway-level targets with potential therapeutic relevance for HSK-associated CNV.
Most-cited papers in Ocular Diseases and Behçet’s Syndrome
- Development of Adverse Sequelae in Children Born with Subclinical Congenital Toxoplasma Infection · PEDIATRICS · 1980 · 370 citations
- Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder · Annals of Neurology · 2023 · 207 citations
- Adalimumab therapy for childhood uveitis · The Journal of Pediatrics · 2006 · 149 citations
- Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 1 · Ophthalmology · 2021 · 85 citations
- Ocular Monkeypox — United States, July–September 2022 · MMWR Morbidity and Mortality Weekly Report · 2022 · 83 citations
- Uveitis in Adults · JAMA · 2025 · 83 citations
- Uveitis Therapy: The Corticosteroid Options · Drugs · 2020 · 80 citations
- Satralizumab: First Approval · Drugs · 2020 · 76 citations
- Drug-Induced Uveitis · Drug Safety · 1997 · 72 citations
- PRESUMED FOVEAL BACILLARY LAYER DETACHMENT IN A PATIENT WITH TOXOPLASMOSIS CHORIORETINITIS AND PACHYCHOROID DISEASE · RETINAL Cases & Brief Reports · 2021 · 67 citations
Most recent work
- EULAR recommendations for the management of Behçet’s syndrome: 2025 update · Annals of the Rheumatic Diseases · 2026
- Varicella-Zoster Virus and the Eye: Clinical Spectrum, Management, and Vaccination · Pathogens · 2026
- Revolutionizing uveitis treatment with nanotechnology: Innovations, barriers, and strategic solutions · Biomedicine & Pharmacotherapy · 2026
- Molecular Pathways Driving Corneal Neovascularization in Herpes Simplex Keratitis · Pathogens · 2026
- Choroidal Vascular Findings in a Case of Multifocal Geographic Atrophy: A Clinicopathologic Correlation · Investigative Ophthalmology & Visual Science · 2026
- Pigment loss and pseudo-albinism in Birdshot chorioretinitis · Eye · 2026
- Adalimumab Reprograms M1 Macrophages to Attenuate Th1/Th17 Responses in Behçet's Uveitis and Vogt–Koyanagi–Harada Syndrome · Investigative Ophthalmology & Visual Science · 2026
- miR-223-3p improves macrophage polarization balance and mitochondrial metabolism to ameliorate uveitis by orchestrating P65Lys310 acetylation through RBPJ/HDAC1 axis · Cellular & Molecular Biology Letters · 2026
- PERIVASCULAR MULTIFOCAL CHOROIDITIS WITH PANUVEITIS: Clinical and Multimodal Imaging Features · Retina · 2026
- Type III interferons attenuates Th1/Th17 cell pathogenicity and regulates retinal pigment epithelium cells via NLRP1/NLRP3 signaling axis in autoimmune uveitis · Genes & Diseases · 2026
Find a gap in your own Ocular Diseases and Behçet’s Syndrome sub-topic
This page shows what the Ocular Diseases and Behçet’s Syndrome literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 4.5M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →